NCT02557373

Brief Summary

The purpose of this study is to assess feasibility of rice bran consumption in weaning children and to identify dietary rice bran mediated changes to the stool microbiome and stool metabolome.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2015

Shorter than P25 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 11, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 23, 2015

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

July 21, 2017

Status Verified

July 1, 2017

Enrollment Period

9 months

First QC Date

September 11, 2015

Last Update Submit

July 18, 2017

Conditions

Keywords

rice braninfantsstool metabolome and microbiomedietary intervention

Outcome Measures

Primary Outcomes (1)

  • Number of participants who are compliant to consuming rice bran daily and in amounts provided.

    Record daily rice bran consumption and track compliance to diet intervention by regular visits from local community health workers.

    3 months

Secondary Outcomes (2)

  • Number of participants with microbial modulations in stool as detected by microbiome sequencing

    3 months

  • Number of participants with metabolite modulations in stool as detected by Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS)

    3 months

Study Arms (2)

Vitamin A

PLACEBO COMPARATOR

Randomized participants will receive a one-dose of vitamin A supplementation (100,000 IU) at the beginning of the trial.

Dietary Supplement: Vitamin A

Rice Bran + Vitamin A

EXPERIMENTAL

Randomized participants will receive a one-dose of vitamin A supplementation (100,000 IU) at the beginning of the trial plus consume a measured dose of rice bran daily.

Dietary Supplement: Rice Bran + Vitamin A

Interventions

Vitamin ADIETARY_SUPPLEMENT

100,000 IU (oral supplement) on Day 1 of the intervention. No additional Vitamin A supplementation.

Vitamin A
Rice Bran + Vitamin ADIETARY_SUPPLEMENT

100,000 IU (oral supplement) on Day 1 of the intervention. No additional Vitamin A supplementation. Dietary rice bran consumed daily and amounts increase throughout the 3 month intervention (6 months of age: 1 g/day rice bran, 7 months: 2 g/day rice bran, 8 months: 3 g/day)

Also known as: whole food dietary intervention
Rice Bran + Vitamin A

Eligibility Criteria

Age4 Months - 10 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children between the ages of 4-6 months at beginning of recruitment
  • Families willing to feed their infant a daily dose of study-provided heat-stabilized rice bran supplementation for 3 months
  • Hemoglobin level \>7 g/dl
  • Absence of intestinal parasites or malaria infection
  • Have not yet received Vitamin A supplementation

You may not qualify if:

  • Have had a diarrheal episode between 5 and 6 months of age
  • Have had a prior hospitalization
  • Have had an antibiotic or prophylactic treatment within 1 month prior to participation
  • Have an ongoing illness, a known immunocompromising condition, or use of medications
  • Hemoglobin level \<7 g/dl
  • Presence of intestinal parasites or malaria infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Colorado State University

Fort Collins, Colorado, 80523, United States

Location

University of Science, Techniques and Technologies of Bamako

Bamako, Mali

Location

Related Publications (6)

  • Goodyear A, Kumar A, Ehrhart EJ, Swanson KS, Grusak MA, Leach JE, Dow SW, McClung A, Ryan EP. Dietary rice bran supplementation differentially prevents Salmonella colonization across varieties and by priming intestinal immunity. J Funct Foods (2015 - in press).

    BACKGROUND
  • Yang X, Wen K, Tin C, Li G, Wang H, Kocher J, Pelzer K, Ryan E, Yuan L. Dietary rice bran protects against rotavirus diarrhea and promotes Th1-type immune responses to human rotavirus vaccine in gnotobiotic pigs. Clin Vaccine Immunol. 2014 Oct;21(10):1396-403. doi: 10.1128/CVI.00210-14. Epub 2014 Jul 30.

    PMID: 25080551BACKGROUND
  • Borresen EC, Ryan EP. Rice Bran: A food ingredient with Global Public Health Opportunities In: Watson RR, Preedy, V. R. and Zibadi, S.,editor. Wheat and Rice in Disease Prevention and Health: Benefits, risks, and mechanisms of whole grains in health promotion. 1st ed. Oxford, UK: Elsevier; 2014 p. 301-11.

    BACKGROUND
  • Kumar A, Henderson A, Forster GM, Goodyear AW, Weir TL, Leach JE, Dow SW, Ryan EP. Dietary rice bran promotes resistance to Salmonella enterica serovar Typhimurium colonization in mice. BMC Microbiol. 2012 Jul 4;12:71. doi: 10.1186/1471-2180-12-71.

    PMID: 22583915BACKGROUND
  • Henderson AJ, Kumar A, Barnett B, Dow SW, Ryan EP. Consumption of rice bran increases mucosal immunoglobulin A concentrations and numbers of intestinal Lactobacillus spp. J Med Food. 2012 May;15(5):469-75. doi: 10.1089/jmf.2011.0213. Epub 2012 Jan 16.

    PMID: 22248178BACKGROUND
  • Borresen EC, Stone C, Bore A, Cissoko A, Maiga A, Koita OA, Ryan EP. Assessing Community Readiness to Reduce Childhood Diarrheal Disease and Improve Food Security in Dioro, Mali. Int J Environ Res Public Health. 2016 Jun 8;13(6):571. doi: 10.3390/ijerph13060571.

MeSH Terms

Interventions

Vitamin A

Intervention Hierarchy (Ancestors)

RetinoidsCarotenoidsPolyenesAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCyclohexenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicTerpenesDiterpenesPigments, BiologicalBiological Factors

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 11, 2015

First Posted

September 23, 2015

Study Start

August 1, 2015

Primary Completion

May 1, 2016

Study Completion

May 1, 2016

Last Updated

July 21, 2017

Record last verified: 2017-07

Locations